Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.

Winkler MT, Bushey RT, Gottlin EB, Campa MJ, Guadalupe ES, Volkheimer

AD, Weinberg JB, Patz EF Jr.

PLoS One. 2017 Jun 28;12(6):e0179841. doi:

10.1371/journal.pone.0179841. eCollection 2017.

PMID: 28658265 [PubMed – in process] Free PMC Article

Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Wang Y, Sun SN, Liu Q, Yu YY, Guo J, Wang K, Xing BC, Zheng QF, Campa

MJ, Patz EF Jr, Li SY, He YW.

Cancer Discov. 2016 Sep;6(9):1022-35. doi:

10.1158/2159-8290.CD-15-1412. Epub 2016 Jun 13.

PMID: 27297552 [PubMed – in process]

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.

Bushey RT, Moody MA, Nicely NL, Haynes BF, Alam SM, Keir ST, Bentley

RC, Roy Choudhury K, Gottlin EB, Campa MJ, Liao HX, Patz EF Jr.

Cell Rep. 2016 May 17;15(7):1505-13. doi: 10.1016/j.celrep.2016.04.038.

Epub 2016 May 5.

PMID: 27160908 [PubMed – in process] Free PMC Article

Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.

Campa MJ, Moody MA, Zhang R, Liao HX, Gottlin EB, Patz EF Jr.

Cancer Immunol Immunother. 2016 Feb;65(2):171-80. doi:

10.1007/s00262-015-1787-0. Epub 2016 Jan 6.

PMID: 26739486 [PubMed – indexed for MEDLINE]

Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy.

Campa MJ, Gottlin EB, Bushey RT, Patz EF Jr.

Cancer Immunol Res. 2015 Dec;3(12):1325-32. doi:

10.1158/2326-6066.CIR-15-0122. Epub 2015 Jul 27.

PMID: 26216416 [PubMed – indexed for MEDLINE] Free Article